参松养心胶囊治疗病毒性心肌炎的Meta分析
2017-08-26张树丹李琪杜昌盛
张树丹++李琪++杜昌盛


[摘要]目的 系统评价参松养心胶囊治疗病毒性心肌炎的效果和安全性,为参松养心胶囊治疗病毒性心肌炎提供相关的循证医学依据。方法 计算机检索PubMed、EMbase、Cochrane Library、CBM、WanFang、CNKI和VIP数据库建库至2016年11月4日的CCT和RCT,并对全部纳入文献的参考文献进行追溯,由两位评价者根据纳入排除标准独立对文献进行筛选和评价,然后进行数据提取。运用RevMan 5.3软件进行统计分析。结果 共纳入12篇文献,Meta分析显示,参松养心组对病毒性心肌炎的临床综合疗效优于西药组(OR值为3.19,95%可信区间为2.14~4.74,P<0.01);参松养心组对病毒性心肌炎室性心律失常的疗效优于西药组(OR值为3.64,95%可信区间为2.50~5.30,P<0.01);参松养心组的不良反应事件发生率低且较轻微。结论 参松养心胶囊治疗病毒性心肌炎的效果显著,安全性较好。
[关键词]参松养心胶囊;病毒性心肌炎;Meta分析
[中图分类号] R542.2+1 [文献标识码] A [文章编号] 1674-4721(2017)07(c)-0007-04
Meta-analysis of Shensongyangxin Capsules treating viral myocarditis
ZHANG Shu-dan1 LI Qi2 DU Chang-sheng1
1.Department of Pharmacy,Dalian Hospital of Traditional Chinese Medicine in Liaoning Province,Dalian 116013,China;2.Department of Internal Medicine,the Third Hospital of Wafangdian in Liaoning Province,Dalian 116300,China
[Abstract]Objective To review systematically the effect and safety of Shensongyangxin Capsules treating viral myocarditis,and provide the related basis of evidence based medicine for Shensongyangxin Capsules treating viral myocarditis.Methods PubMed,EMbase,Cochrane Library,CBM,WanFang,CNKI and VIP were retrieved using the computer for collecting RCT and CCT for database construction to November 4,2016,and all references included in the literature were traced.According to the inclusion and exclusion criteria,two reviewers screened and assessed independently the literature,and then the data was extracted.The data was given a Meta-analysis by using RevMan 5.3 software.Results 12 study articles were included.Meta-analysis showed that the clinical curative effect of the Shensongyangxin group treating viral myocarditis was better than the Western medicine group (OR=3.19,95%CI:2.14-4.74,P<0.01).The clinical curative effect of the Shensongyangxin group treating ventricular arrhythmia was better than the Western medicine group (OR=3.64,95%CI:2.50-5.30,P<0.01).The occurrence rate of adverse events was lower and the reactions was low and mild in the Shensongyangxin group.Conclusion Shensongyangxin Capsules has a significant curative effect treating viral myocarditis,and the safety is good.
[Key words]Shensongyangxin Capsules;Viral myocarditis;Meta-analysis
病毒性心肌炎是指病毒感染侵犯心肌導致心肌损伤后免疫细胞浸润心肌所引起的心肌局限性或弥漫性的急性或慢性炎性病变[1]。现代化研究手段使人们对心肌炎发病机制的认识有了长足的进步,但是西方医学对病毒性心肌炎的临床治疗却进步甚微[2],尚无特异性治疗方法,通常仅采取对症治疗,导致临床医师缺乏对此病治愈的信心,而与西医形成鲜明对比的是中医在治疗病毒性心肌炎方面则取得了良好的进展[3-4]。其代表药物有参松养心胶囊、稳心颗粒、玉丹荣心丸等。中药最大的优点在于不良反应少,患者易于耐受。本文旨在系统评价参松养心胶囊治疗病毒性心肌炎的效果和安全性,以期为参松养心胶囊治疗病毒性心肌炎提供相关的循证医学证据。
1 资料与方法
1.1 文献纳入和排除标准……p>
